- Insider Monkey
Is Genmab A/S (GMAB) One of the Best Revenue Growth Stocks to Buy According to Analysts?
We recently published a list of the 7 Best Revenue Growth Stocks to Buy According to Analysts. In this article, we are going to take a look at where Genmab A/S (NASDAQ:GMAB) stands against the other best revenue growth stocks to buy according to analysts. The Fed recently cut the funds rate by 50 basis […]
- Insider Monkey
Genmab A/S (GMAB): One of the Best Affordable Stocks Under $40 According to Short Sellers
We recently compiled a list of the 10 Best Affordable Stocks Under $40 According to Short Sellers. In this article, we are going to take a look at where Genmab A/S (NASDAQ:GMAB) stands against the other affordable stocks under $40. Several traders tend to profit from stocks through appreciation. However, some do the opposite– their idea […]
- Zacks
AbbVie (ABBV) Gets Nod in EU for Lymphoma Drug's Expanded Use
AbbVie's (ABBV) Tepkinly gets conditional approval in the EU to treat third-line patients with relapsed or refractory follicular lymphoma as a second indication.
